Literature DB >> 1713016

The development of rational strategies for selective immunotherapy against autoimmune demyelinating disease.

L Steinman1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1713016     DOI: 10.1016/s0065-2776(08)60779-8

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


× No keyword cloud information.
  12 in total

1.  Adeno-associated viral-mediated catalase expression suppresses optic neuritis in experimental allergic encephalomyelitis.

Authors:  J Guy; X Qi; W W Hauswirth
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

2.  In search of TCR restriction in autoreactive T cell in human autoimmunity: why is it so elusive?

Authors:  C Navarrete; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

3.  Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use.

Authors:  S Kaveri; T Vassilev; V Hurez; R Lengagne; C Lefranc; S Cot; P Pouletty; D Glotz; M D Kazatchkine
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

Review 4.  Novel approaches in immunotherapy.

Authors:  J M Saint-Remy
Journal:  Clin Rev Allergy       Date:  1994

5.  Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis.

Authors:  Anna Corcione; Simona Casazza; Elisa Ferretti; Debora Giunti; Emanuela Zappia; Angela Pistorio; Claudio Gambini; Giovanni Luigi Mancardi; Antonio Uccelli; Vito Pistoia
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

6.  Identification of a pathogenic epitope involved in initiation of Heymann nephritis.

Authors:  D Kerjaschki; R Ullrich; K Diem; S Pietromonaco; R A Orlando; M G Farquhar
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

7.  Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases.

Authors:  K Gijbels; R E Galardy; L Steinman
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

8.  Novel members and germline polymorphisms in the human T-cell receptor Vb6 family.

Authors:  M Gomolka; C Epplen; J Buitkamp; J T Epplen
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

9.  Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production.

Authors:  N Karin; D J Mitchell; S Brocke; N Ling; L Steinman
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

10.  Borna disease virus-specific T cells protect against or cause immunopathological Borna disease.

Authors:  J A Richt; A Schmeel; K Frese; K M Carbone; O Narayan; R Rott
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.